Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Diabetologia
Published in: Diabetologia 11/2014

01-11-2014 | Article

Downregulation of the acetyl-CoA metabolic network in adipose tissue of obese diabetic individuals and recovery after weight loss

Authors: Harish Dharuri, Peter A. C. ’t Hoen, Jan B. van Klinken, Peter Henneman, Jeroen F. J. Laros, Mirjam A. Lips, Fatiha el Bouazzaoui, Gert-Jan B. van Ommen, Ignace Janssen, Bert van Ramshorst, Bert A. van Wagensveld, Hanno Pijl, Ko Willems van Dijk, Vanessa van Harmelen

Published in: Diabetologia | Issue 11/2014

Login to get access

Abstract

Aims/hypothesis

Not all obese individuals develop type 2 diabetes. Why some obese individuals retain normal glucose tolerance (NGT) is not well understood. We hypothesise that the biochemical mechanisms that underlie the function of adipose tissue can help explain the difference between obese individuals with NGT and those with type 2 diabetes.

Methods

RNA sequencing was used to analyse the transcriptome of samples extracted from visceral adipose tissue (VAT) and subcutaneous adipose tissue (SAT) of obese women with NGT or type 2 diabetes who were undergoing bariatric surgery. The gene expression data was analysed by bioinformatic visualisation and statistical analyses techniques.

Results

A network-based approach to distinguish obese individuals with NGT from obese individuals with type 2 diabetes identified acetyl-CoA metabolic network downregulation as an important feature in the pathophysiology of type 2 diabetes in obese individuals. In general, genes within two reaction steps of acetyl-CoA were found to be downregulated in the VAT and SAT of individuals with type 2 diabetes. Upon weight loss and amelioration of metabolic abnormalities three months following bariatric surgery, the expression level of these genes recovered to levels seen in individuals with NGT. We report four novel genes associated with type 2 diabetes and recovery upon weight loss: ACAT1 (encoding acetyl-CoA acetyltransferase 1), ACACA (encoding acetyl-CoA carboxylase α), ALDH6A1 (encoding aldehyde dehydrogenase 6 family, member A1) and MTHFD1 (encoding methylenetetrahydrofolate dehydrogenase).

Conclusions/interpretation

Downregulation of the acetyl-CoA network in VAT and SAT is an important feature in the pathophysiology of type 2 diabetes in obese individuals. ACAT1, ACACA, ALDH6A1 and MTHFD1 represent novel biomarkers in adipose tissue associated with type 2 diabetes in obese individuals.
Appendix
Available only for authorised users
Literature
1.
Malik VS, Willett WC, Hu FB (2013) Global obesity: trends, risk factors and policy implications. Nat Rev Endocrinol 1:13–27
2.
Mokdad AH, Ford ES, Bowman BA et al (2003) Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 289:76–79PubMedCrossRef
3.
Van Gaal LF, Mertens IL, de Block CE (2006) Mechanisms linking obesity with cardiovascular disease. Nature 444:875–880PubMedCrossRef
4.
Bluher M (2012) Are there still healthy obese patients? Curr Opin Endocrinol Diabetes Obes 19:341–346PubMedCrossRef
5.
Bluher M (2013) Adipose tissue dysfunction contributes to obesity related metabolic diseases. Best Pract Res Clin Endocrinol Metab 27:163–177PubMedCrossRef
6.
Kantartzis K, Machann J, Schick F et al (2011) Effects of a lifestyle intervention in metabolically benign and malign obesity. Diabetologia 54:864–868PubMedCrossRef
7.
Lindstrom J, Tuomilehto J (2003) The diabetes risk score: a practical tool to predict type 2 diabetes risk. Diabetes Care 26:725–731PubMedCrossRef
8.
Pajunen P, Kotronen A, Korpi-Hyovalti E et al (2011) Metabolically healthy and unhealthy obesity phenotypes in the general population: the FIN-D2D Survey. BMC Public Health 11:754PubMedCrossRefPubMedCentral
9.
Wolfs MG, Rensen SS, Bruin-Van Dijk EJ et al (2010) Co-expressed immune and metabolic genes in visceral and subcutaneous adipose tissue from severely obese individuals are associated with plasma HDL and glucose levels: a microarray study. BMC Med Genomics 3:34PubMedCrossRefPubMedCentral
10.
Klikacova E, Roussel B, Marquez-Quinones A et al (2011) Worsening of obesity and metabolic status yields similar molecular adaptations in human subcutaneous and visceral adipose tissue: decreased metabolism and increased immune response. J Clin Endocrinol Metab 96:E73–E82CrossRef
11.
Qatanani M, Tan Y, Dobrin R et al (2013) Inverse regulation of inflammation and mitochondrial function in adipose tissue defines extreme insulin sensitivity in morbidly obese patients. Diabetes 62:855–863PubMedCrossRefPubMedCentral
12.
Mortazavi A, Williams BA, McCue K, Schaeffer L, Wold B (2008) Mapping and quantifying mammalian transcriptomes by RNA-Seq. Nat Methods 5:621–628PubMedCrossRef
13.
14.
15.
Van Harmelen V, Lonnqvist F, Thorne A et al (1997) Noradrenaline-induced lipolysis in isolated mesenteric, omental and subcutaneous adipocytes from obese subjects. Int J Obes Relat Metab Disord 21:972–979PubMedCrossRef
16.
Goeman JJ, van de Geer SA, de Kort F, van Houwelingen HC (2004) A global test for groups of genes: testing association with a clinical outcome. Bioinformatics 20:93–99PubMedCrossRef
17.
18.
19.
20.
Naimi M, Arous C, van Obberghen E (2010) Energetic cell sensors: a key to metabolic homeostasis. Trends Endocrinol Metab 21:75–82PubMedCrossRef
21.
Herman MA, She P, Peroni OD, Lynch CJ, Kahn BB (2010) Adipose tissue branched chain amino acid (BCAA) metabolism modulates circulating BCAA levels. J Biol Chem 285:11348–11356PubMedCrossRefPubMedCentral
22.
Dahlman I, Forsgren M, Sjogren A et al (2006) Downregulation of electron transport chain genes in visceral adipose tissue in type 2 diabetes independent of obesity and possibly involving tumor necrosis factor-alpha. Diabetes 55:1792–1799PubMedCrossRef
23.
24.
Cai L, Sutter BM, Li B, Tu BP (2011) Acetyl-CoA induces cell growth and proliferation by promoting the acetylation of histones at growth genes. Mol Cell 42:426–437PubMedCrossRefPubMedCentral
25.
Cai L, Tu BP (2011) On acetyl-CoA as a gauge of cellular metabolic state. Cold Spring Harb Symp Quant Biol 76:195–202PubMedCrossRef
26.
Sahoo S, Franzson L, Jonsson JJ, Thiele I (2012) A compendium of inborn errors of metabolism mapped onto the human metabolic network. Mol Biosyst 8:2545–2558PubMedCrossRef
27.
Thiele I, Swainston N, Fleming RM et al (2013) A community-driven global reconstruction of human metabolism. Nat Biotechnol 31:419–425PubMedCrossRef
28.
Haapalainen AM, Merilainen G, Pirila PL, Kondo N, Fukao T, Wierenga RK (2007) Crystallographic and kinetic studies of human mitochondrial acetoacetyl-CoA thiolase: the importance of potassium and chloride ions for its structure and function. Biochemistry 46:4305–4321PubMedCrossRef
29.
GoDARTS and UKPDS Diabetes Pharmacogenetics Study Group, Wellcome Trust Case Control Consortium, Zhou K et al (2011) Common variants near ATM are associated with glycemic response to metformin in type 2 diabetes. Nat Genet 43:117–120PubMedCrossRefPubMedCentral
30.
31.
Lappalainen T, Sammeth M, Friedlander MR et al (2013) Transcriptome and genome sequencing uncovers functional variation in humans. Nature 501:506–511PubMedCrossRefPubMedCentral
32.
’t Hoen PA, Friedlander MR, Almlof J et al (2013) Reproducibility of high-throughput mRNA and small RNA sequencing across laboratories. Nat Biotechnol 31:1015–1022PubMedCrossRef
33.
Soronen J, Laurila PP, Naukkarinen J et al (2012) Adipose tissue gene expression analysis reveals changes in inflammatory, mitochondrial respiratory and lipid metabolic pathways in obese insulin-resistant subjects. BMC Med Genomics 5:9PubMedCrossRefPubMedCentral
34.
Karelis AD, Faraj M, Bastard JP et al (2005) The metabolically healthy but obese individual presents a favorable inflammation profile. J Clin Endocrinol Metab 90:4145–4150PubMedCrossRef
35.
Naukkarinen J, Heinonen S, Hakkarainen A et al (2014) Characterising metabolically healthy obesity in weight-discordant monozygotic twins. Diabetologia 57:167–176PubMedCrossRef
36.
Phillips CM, Perry IJ (2013) Does inflammation determine metabolic health status in obese and nonobese adults? J Clin Endocrinol Metab 98:E1610–E1619PubMedCrossRef
Metadata
Title
Downregulation of the acetyl-CoA metabolic network in adipose tissue of obese diabetic individuals and recovery after weight loss
Authors
Harish Dharuri
Peter A. C. ’t Hoen
Jan B. van Klinken
Peter Henneman
Jeroen F. J. Laros
Mirjam A. Lips
Fatiha el Bouazzaoui
Gert-Jan B. van Ommen
Ignace Janssen
Bert van Ramshorst
Bert A. van Wagensveld
Hanno Pijl
Ko Willems van Dijk
Vanessa van Harmelen
Publication date
01-11-2014
Publisher
Springer Berlin Heidelberg
Published in
Diabetologia / Issue 11/2014
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-014-3347-0

Other articles of this Issue 11/2014

Diabetologia 11/2014 Go to the issue

Article

A CD40-targeted peptide controls and reverses type 1 diabetes in NOD mice

Article

Higher dietary salt intake is associated with microalbuminuria, but not with retinopathy in individuals with type 1 diabetes: the EURODIAB Prospective Complications Study

Article

A low disposition index in adolescent offspring of mothers with gestational diabetes: a risk marker for the development of impaired glucose tolerance in youth

Article

Global DNA methylation levels in human adipose tissue are related to fat distribution and glucose homeostasis

Article

Macrophage mTORC1 disruption reduces inflammation and insulin resistance in obese mice

Letter

Timing and intensity of exercise for glucose control
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits